Fed Housing Shock Tests Homebuilder Margins

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

The Federal Reserve’s decision lands at an unusually sensitive moment for housing. The Fed Housing Shock is arriving just as markets are pricing roughly a 93% probability of a 25-basis-point rate increase, while daily mortgage-rate measures have pushed back above 7% as long-term Treasury yields remain elevated. For prospective homebuyers already stretched by high prices, that combination makes the monthly-payment equation even harder.

That is the backdrop confronting a major U.S. homebuilder reporting after the close. Consensus expectations point to roughly $8.4 billion of revenue and $1.30 of EPS, both below last year, while management has already guided to only modest sequential improvement in home-sale gross margin.

 

The obvious debate is whether tonight’s quarter clears those numbers. The more important question is what the Fed-driven rate environment means for the next two quarters.

Because the quarter being reported ended August 31, the latest mortgage-rate shock arrived too late to reshape most Q3 closings. Tonight is therefore less about what 7% mortgages did to Q3 than what they could do next.

The Fed Housing Shock & The Priced-In Scenario

Wall Street is not expecting a breakout quarter from Lennar Corporation (NYSE: LEN). Revenue is expected around $8.3 billion to $8.4 billion, while EPS estimates cluster near $1.28 to $1.30. Management itself guided to Q3 deliveries of 20,500 to 21,500 homes, new orders of 21,000 to 22,000, and an average selling price between $375,000 and $380,000.

The most important expectation...

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Eli Lilly Acquisition: What Calytrix Bio Adds To Oncology

Eli Lilly and Company (NYSE:LLY) is making a move...

Diamondback Energy’s $5 Billion Double Eagle Acquisition Gamble

Diamondback Energy (NASDAQ:FANG) could be preparing another major move...

Tandem Diabetes Care: FDA Clears 7-Day Tubeless Pump

Tandem Diabetes Care (NASDAQ:TNDM) has secured an important regulatory...

CoreWeave Insider Selling: Why CEO Paused After $794 Million

CoreWeave (NASDAQ: CRWV) has given investors an unusual question...

Nvidia Jensen Scandal: Can Nvidia Survive Without Huang?

What happens when the man who helped build the...

Related Articles

Eli Lilly Acquisition: What Calytrix Bio Adds To Oncology

Eli Lilly and Company (NYSE:LLY) is making a move...

Diamondback Energy’s $5 Billion Double Eagle Acquisition Gamble

Diamondback Energy (NASDAQ:FANG) could be preparing another major move...

Tandem Diabetes Care: FDA Clears 7-Day Tubeless Pump

Tandem Diabetes Care (NASDAQ:TNDM) has secured an important regulatory...

CoreWeave Insider Selling: Why CEO Paused After $794 Million

CoreWeave (NASDAQ: CRWV) has given investors an unusual question...

Nvidia Jensen Scandal: Can Nvidia Survive Without Huang?

What happens when the man who helped build the...

Micron Stock Forecast: Could AI Fuel 148% Upside?

Micron Technology (NASDAQ: MU) has become one of Wall...

Telos Cybersecurity Contracts: $58M Wins, AI &Valuation

Telos Corporation (NASDAQ: TLS) is experiencing renewed momentum as...

indie Semiconductor Stock: $6.2B Backlog & Robotics Opportunity

indie Semiconductor, Inc. (NASDAQ: INDI) is expanding beyond automotive...
spot_img

Related Articles

Popular Categories

spot_imgspot_img